• Issues
    • COVID-19
    • Pharmacy Direct and Indirect Remuneration (DIR)
    • Drug Pricing Issues
      • Insulin
    • Health Equity
    • Patient Care
    • PBMs and Pharmacies
      • Mail-Service Pharmacy
      • Specialty Pharmacies
    • PBM Tools
    • Rebates
      • Prescription Drug Rebate Rule
    • Transparency
    • Value of PBMs
  • Newsroom
    • Press Releases
    • CEO’s Perspective
    • The Pharmacy Benefit Podcast
    • The Pharmacy Benefit Brief
    • Research
      • Rx Research Corner
    • Infographics
    • News Highlights
  • About PCMA
    • PCMA Members
    • PCMA Board of Directors
    • PCMA Affiliates
    • PCMA Team
  • PCMA Events
    • 2022 Events
    • Past Events
    • Event Content & Highlights
  • Member Login
  • Industry Relations Login
Search
START TYPING AND PRESS ENTER TO SEARCH
  • Issues
    • COVID-19
    • Pharmacy Direct and Indirect Remuneration (DIR)
    • Drug Pricing Issues
      • Insulin
    • Health Equity
    • Patient Care
    • PBMs and Pharmacies
      • Mail-Service Pharmacy
      • Specialty Pharmacies
    • PBM Tools
    • Rebates
      • Prescription Drug Rebate Rule
    • Transparency
    • Value of PBMs
  • Newsroom
    • Press Releases
    • CEO’s Perspective
    • The Pharmacy Benefit Podcast
    • The Pharmacy Benefit Brief
    • Research
      • Rx Research Corner
    • Infographics
    • News Highlights
  • About PCMA
    • PCMA Members
    • PCMA Board of Directors
    • PCMA Affiliates
    • PCMA Team
  • PCMA Events
    • 2022 Events
    • Past Events
    • Event Content & Highlights
  • Member Login
  • Industry Relations Login
Search

JC Scott testifies before a Senate panel about PBM value.

May 5, 2022

PBMs are proud of the work they do to reduce prescription drug costs, expand affordable access to medications, and improve patient outcomes.

Read More »

FTC’s inquiry of PBMs won’t lower prescription drug costs

April 19, 2022

I recently had the opportunity to participate in a listening forum at the Federal Trade Commission (FTC) on competition in the health care industry where I shared my thoughts on what needs to be done to make prescription drugs more affordable — a goal we firmly support.

Read More »

PBMs: Improving Patients’ Pharmacy Experience and Health Outcomes

February 16, 2022
Read More »

JC Scott: PBMs Streamline Access to COVID-19 Testing

January 25, 2022
Read More »

PBMs Use Evidence in Determining Aduhelm Coverage

December 16, 2021
Read More »

Pharmacy Benefit Managers Prepared for Introduction of Aduhelm

November 2, 2021
Read More »

PBMs: Applauding FDA Approval of the First Biosimilar Insulin Product

August 9, 2021
Read More »

Pharmacy Benefit Managers Unveil a Critical Path Forward to Reduce Prescription Drug Costs

June 23, 2021
Read More »

Morning Consult: Congress Should Act Quickly to Permanently Repeal the Rebate Rule

April 12, 2021
Read More »

12 Ways Pharmacy Benefit Managers Are Helping Patients Access COVID-19 Vaccines

March 19, 2021